.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
QuintilesIMS
Chinese Patent Office
Queensland Health
McKesson
Julphar
Merck
Federal Trade Commission
McKinsey
Accenture

Generated: June 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040416

« Back to Dashboard
NDA 040416 describes JANTOVEN, which is a drug marketed by Usl Pharma and is included in one NDA. It is available from two suppliers. Additional details are available on the JANTOVEN profile page.

The generic ingredient in JANTOVEN is warfarin sodium. There are twenty-one drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the warfarin sodium profile page.

Summary for NDA: 040416

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Blood Products/Modifiers/ Volume Expanders
Formulation / Manufacturing:see details

Pharmacology for NDA: 040416

Mechanism of ActionVitamin K Inhibitors

Suppliers and Packaging for NDA: 040416

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
JANTOVEN
warfarin sodium
TABLET;ORAL 040416 ANDA Upsher-Smith Laboratories, Inc. 0832-1211 0832-1211-00 100 TABLET in 1 BOTTLE (0832-1211-00)
JANTOVEN
warfarin sodium
TABLET;ORAL 040416 ANDA Upsher-Smith Laboratories, Inc. 0832-1211 0832-1211-01 10 BLISTER PACK in 1 CARTON (0832-1211-01) > 10 TABLET in 1 BLISTER PACK (0832-1211-89)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1MG
Approval Date:Oct 2, 2003TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2MG
Approval Date:Oct 2, 2003TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2.5MG
Approval Date:Oct 2, 2003TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Chinese Patent Office
Cantor Fitzgerald
Healthtrust
Covington
Colorcon
UBS
Chubb
Dow
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot